Zborník príspevkov z vedeckej konferencie - Department of ...
Zborník príspevkov z vedeckej konferencie - Department of ... Zborník príspevkov z vedeckej konferencie - Department of ...
Záver Pri úprave vzorky pôdy metódou disperzie matrice na tuhej fáze okrem špecifického chromatografického stpca pozostávajúceho zo vzorky pôdy homogenizovanej so sorbentom v pomere hmotností 1:1 sa na dno kolóny za sucha poklepkávaním plní vrstva sorbentu. Pomer hmotnosti sorbentu ku hmotnosti vzorky pôdy 1:1 vyplynul zo štúdia v práci [14]. V dôsledku toho získaný desorbát je íry a nie je potrebné ho pred odparením filtrova alebo centrifugova. Práca je zameraná na optimalizáciu extrakných parametrov a to objemu extrakného inidla, objemu zachytenej frakcie, objemu odparku, koneného objemu vzorky a prietokovej rýchlosti extrakného inidla. Pri MSPD sa na koncentranej úrovni 2,5 μg/g úinnosti extrakcie pohybovali pre prídavok zmesného štandardu do extraktu nekontaminovanej vzorky pôdy v rozmedzí 84-109 % a pre kontaminovanú pôdnu vzorku 62-94%. Detekné limity pesticídov sa pohybovali v rozmedzí 31- 87 ng/ml dávkovaného roztoku zmesi analytov. Práca vznikla za podpory projektov APVV-0597-07 , VVCE-0070-07, VEGA 1/0870/09. Literatúra [ 1] http://www.alanwood.net/pesticides , 13:00, 11.10.2008. [ 2] http://www.agrocourier.com/bayer/cropscience/cscms.nsf/id/Safener_ 10:00, 20.2.2009. [ 3] www.wikipedia.org , 10:00, 30.9.2008. [ 4] http://www.beyondpesticides.org/infoservices/pesticidefactsheets/toxic/pyrethroid.htm , 25.3.2005. [ 5] J. Garey, M. S. Wolf, Biochemical and Biophysical research communications 251, (1998) 855. [ 6] http://www.land.gov.sk/sk/index.php?navID=21&navID2=21&sID=23&id=385 , 16:00, 8.3.2009. [ 7] M. Kirchner, E. Matisova: Súasné metódy a nové trendy v izolácii reziduí pesticídov z beztukových potravín, Chem. Listy 98, (2004) 396405. [ 8] S.A. Barker, A.R. Long, in: V.K. Agarwal (Ed.), Analysis of Antibiotic Drug Residues in Food Products of Animal Origin, Plenum Press, New York, (1992) 119. [ 9] S.A. Barker, LC-GC Int. 11 (1998) 719. [10] Steven A. Barker.: Matrix solid-phase dispersion, Journal of Chromatography A, 885, (2000) 115-127. [11] G. Karasová, E. Brandšteterová, M. Lachová, Czech J. Food Sci. Vol. 21 (2003) 219. [12] S.A. Barker, Chemtech 23 (1993) 42. [13]. S.A. Barker, Z.E. Floyd, in: J. Pesek, M. Matyska, R. Abuelafiya (Eds.), Chemically Modified Surfaces: Recent Developments, Royal Society of Chemistry, (1996) 66. [14] Z. Michaloviová, Diplomová práca, Prif UK Bratislava (2005). Zborník príspevkov z 18. medzinárodnej vedeckej konferencie "Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9 - 115 - hotel Falkensteiner, Bratislava 11. - 14. 10. 2010
SIMULTANOUS DETERMINATION OF GALACTITOL AND GALACTOSE IN AQUEOUS SAMPLES BY GAS CHROMATOGRAPHY – MASS SPECTROMETRY IVAN OSTROVSKÝ*, RÓBERT KUBINEC, JAROSLAV BLAŠKO, JOZEF VIŠOVSKÝ, RENÁTA GÓROVÁ, GABRIELA ADDOVÁ, PETER PODOLEC, ALEXANDRA SZABÓOVÁ Chemical Institute, Faculty of Natural Sciences, Comenius University, Mlynská dolina CH-2, SK-845 45 Bratislava, Slovakia e-mail: ostrovsky@rec.uniba.sk Abstract Galactosemia, a metabolic disorder associated with the intolerance of dietary galactose due to an inherited enzymatic deficiency, is indicated by heightened levels of galactose and galactitol in urine. Gas chromatography (GC) with mass spectrometry (MS) detection was evaluated for its ability to screen urinary carbohydrates, particularly galactose and galactitol. The described method uses trimethylsilyl derivates of galactitol and galactose, and needs 100 l of urine for a single run. Spontaneous urine was obtained from 25 healthy subjects (classified into 5 age groups), from 4 treated patients with classical galactosaemia. The age dependences of galactose and galactitol excretion in urine was found in healthy subjects and treated galactosaemic patients by using reported method. Recognizing the clinical need for the simultaneous measurement of galactitol and galactose in urine for galactosaemic subjects, we developed the new GC/MS method, permits for the first time, measurement in urine by an accurate and precise single step procedure. This method does not require urine pretreatment before the silylation. Introduction Metabolism is the sum of all continuous biochemical reactions of breakdown and renewal of tissues of the body. Enzymes play an indispensable role in facilitating the process by serving as catalysts in the conversion of one chemical (metabolite) to another, often extracting the energy required for the reaction from a suitable high energy source, such as ATP [1]. Figure 1 shows the various possible mutation–sensitive defects affecting the compartmentalization and metabolism of compound A. This figure shows schematically the relationship between various defect types and their pathophysiologically and diagnostically important consequences [1]. Membrane 1 2 Holoenzyme Aoutside Ainside B C E 6 Fig. 1. The primary consequences of inborn errors of metabolism. 1–transporter-mediated movement of A from one compartment to another, 2–defect in the conversion of B to C, 3–increased conversion of B to D caused by accumulation of B, 4–defect in the interaction between an apoenzyme and an obligatory cofactor, 5–decreased feedback inhibition of the conversion of Ain to B as a result of deficiency of C, 6–secondary inhibition of the conversion of E to F caused by accumulation of D [1]. D 5 - F 4 Apoenzyme + cofactor “Inborn metabolic diseases” (IMDs) is the term applied to genetic disorders caused by loss of function of an enzyme. Enzyme activity may be low or lacking for variety of reasons. Some IMDs produce relatively unimportant physical features or skeletal abnormalities, but others produce serious diseases and even death. Most inborn errors of metabolism are monitored by blood or urine tests [2]. The phrase “inborn errors of metabolism” had been first used by A. E. Garrod in the Croonian Lectures of 1908, and published as a monograph with this title in 1909 [3]. Traditionally the IMDs are categorized as disorders of carbohydrate metabolism, amino acid metabolism, organic acid metabolism, or lysosomal storage diseases [4]. Galactosemia was first "discovered" in 1908, when Von Ruess reported on a breast-fed infant with failure to thrive, enlargement of the liver and spleen, and "galactosuria" in publication entitled "Sugar Excretion in Infancy". This infant ceased to excrete galactose through urine when milk products were removed from the diet. The toxic syndrome, galactosemia, is associated with an intolerance to dietary galactose as a result of certain enzymatic deficiencies [5]. Malfuctions in the following three enzymes, which participate in the normal metabolism of galactose (Fig. 2), are known to be causes of galactosemia: galactose-1-phosphate uridyltransferase (GALT), galactokinase and uridine diphosphate- Zborník príspevkov z 18. medzinárodnej vedeckej konferencie "Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9 - 116 - hotel Falkensteiner, Bratislava 11. - 14. 10. 2010
- Page 72 and 73: Fig. 1. Chromatogram GC separácie
- Page 74 and 75: OV 1 Obr. 3. Závislos homomorfnýc
- Page 76 and 77: Záver Namerali sa teplotne-program
- Page 78 and 79: modifier solutions for ensure homog
- Page 80 and 81: applied to attain a stabilization o
- Page 82 and 83: against aqueous standards with a pr
- Page 84 and 85: Ludrová (6). Maslo sa vyrobilo zmi
- Page 86 and 87: Tabuka 2. Zloženie mastných kysel
- Page 88 and 89: Tabuka 3. Obsah jednotlivých izom
- Page 90 and 91: [19] J. Blaško, R. Kubinec, I. Ost
- Page 92 and 93: 2. Experimental Instrumentation Flo
- Page 94 and 95: Analysis of real samples The boiler
- Page 96 and 97: a) b) 2 2 1 1 3 3 3 3 Fig. 1 The ex
- Page 98 and 99: Conclusion remarks The identificati
- Page 100 and 101: screening, possible interactions am
- Page 102 and 103: The design consists of a factorial
- Page 104 and 105: elative area 15 10 5 -1,68 -1,00 0,
- Page 106 and 107: It can be seen that the programms d
- Page 108 and 109: nevodíkovými atómami izotropne s
- Page 110 and 111: O22—C6—C7 109.57 (15) C10—C11
- Page 112 and 113: [8] S. Teklu, L.L. Gundersen, T. La
- Page 114 and 115: iónom kovu môže by ovplyvnená a
- Page 116 and 117: V alšej asti práce sme študovali
- Page 118 and 119: vzorky, pomer hmotností vzorky a s
- Page 120 and 121: literatúre nenašli informácie. M
- Page 124 and 125: galactose-4-epimerase [6, 7]. First
- Page 126 and 127: Abundance Abundance Abundance 1x10
- Page 128 and 129: Galactitol [mmol/mol creatinine] 60
- Page 130 and 131: References [1] J.T.R. Clarke, Clini
- Page 132 and 133: structural information of the analy
- Page 134 and 135: (x10,000,000) 1.5 1:TIC (1.00) 1.4
- Page 136 and 137: 1 st fraction 1.5 1.0 0.5 (x10,000,
- Page 138 and 139: 1 st fraction 1.5 1.0 0.5 (x10,000,
- Page 140 and 141: RAPID LIQUID CHROMATOGRAPHY-MASS SP
- Page 142 and 143: the LC-ESI-IT-TOF MS analyzer. HPLC
- Page 144 and 145: (x10,000,000) 1:TIC (1.00) 4:TIC (1
- Page 146 and 147: Figure 5 is showing MS and MS/MS sp
- Page 148 and 149: Figure 7 present MS and MS/MS spect
- Page 150 and 151: MS and MS/MS spectra of potential m
- Page 152 and 153: DVOUROZMĚRNÁ KAPALINOVÁ CHROMATO
- Page 154 and 155: řřů ěř Pnčč ěě : ččěP2D
- Page 156 and 157: řěůčťě čě č ěě Obr. 6.
- Page 158 and 159: Obr. 9. Separaci metabolitů indolo
- Page 160 and 161: STANOVENIE OXIDANÝCH PRODUKTOV OXI
- Page 162 and 163: e d c b a G NO - 3 NO - 2 NO - 2 NO
- Page 164 and 165: Na obr. 4b je elektroforeogram z IT
- Page 166 and 167: Vhodnos navrhnutého analytického
- Page 168 and 169: Experimentálna as CZE separácie b
- Page 170 and 171: Séria kalibraných meraní modelov
Záver<br />
Pri úprave vzorky pôdy metódou disperzie matrice na tuhej fáze okrem špecifického chromatografického stpca<br />
pozostávajúceho zo vzorky pôdy homogenizovanej so sorbentom v pomere hmotností 1:1 sa na dno kolóny za sucha<br />
poklepkávaním plní vrstva sorbentu. Pomer hmotnosti sorbentu ku hmotnosti vzorky pôdy 1:1 vyplynul zo štúdia v práci<br />
[14]. V dôsledku toho získaný desorbát je íry a nie je potrebné ho pred odparením filtrova alebo centrifugova. Práca je<br />
zameraná na optimalizáciu extrakných parametrov a to objemu extrakného inidla, objemu zachytenej frakcie, objemu<br />
odparku, koneného objemu vzorky a prietokovej rýchlosti extrakného inidla. Pri MSPD sa na koncentranej úrovni 2,5<br />
μg/g úinnosti extrakcie pohybovali pre prídavok zmesného štandardu do extraktu nekontaminovanej vzorky pôdy v<br />
rozmedzí 84-109 % a pre kontaminovanú pôdnu vzorku 62-94%. Detekné limity pesticídov sa pohybovali v rozmedzí 31-<br />
87 ng/ml dávkovaného roztoku zmesi analytov.<br />
Práca vznikla za podpory projektov APVV-0597-07 , VVCE-0070-07, VEGA 1/0870/09.<br />
Literatúra<br />
[ 1] http://www.alanwood.net/pesticides , 13:00, 11.10.2008.<br />
[ 2] http://www.agrocourier.com/bayer/cropscience/cscms.nsf/id/Safener_ 10:00, 20.2.2009.<br />
[ 3] www.wikipedia.org , 10:00, 30.9.2008.<br />
[ 4] http://www.beyondpesticides.org/infoservices/pesticidefactsheets/toxic/pyrethroid.htm , 25.3.2005.<br />
[ 5] J. Garey, M. S. Wolf, Biochemical and Biophysical research communications 251, (1998) 855.<br />
[ 6] http://www.land.gov.sk/sk/index.php?navID=21&navID2=21&sID=23&id=385 , 16:00, 8.3.2009.<br />
[ 7] M. Kirchner, E. Matisova: Súasné metódy a nové trendy v izolácii reziduí pesticídov z beztukových potravín, Chem.<br />
Listy 98, (2004) 396405.<br />
[ 8] S.A. Barker, A.R. Long, in: V.K. Agarwal (Ed.), Analysis <strong>of</strong> Antibiotic Drug Residues in Food Products <strong>of</strong> Animal<br />
Origin, Plenum Press, New York, (1992) 119.<br />
[ 9] S.A. Barker, LC-GC Int. 11 (1998) 719.<br />
[10] Steven A. Barker.: Matrix solid-phase dispersion, Journal <strong>of</strong> Chromatography A, 885, (2000) 115-127.<br />
[11] G. Karasová, E. Brandšteterová, M. Lachová, Czech J. Food Sci. Vol. 21 (2003) 219.<br />
[12] S.A. Barker, Chemtech 23 (1993) 42.<br />
[13]. S.A. Barker, Z.E. Floyd, in: J. Pesek, M. Matyska, R. Abuelafiya (Eds.), Chemically Modified Surfaces: Recent<br />
Developments, Royal Society <strong>of</strong> Chemistry, (1996) 66.<br />
[14] Z. Michaloviová, Diplomová práca, Prif UK Bratislava (2005).<br />
<strong>Zborník</strong> <strong>príspevkov</strong><br />
z 18. medzinárodnej <strong>vedeckej</strong> <strong>konferencie</strong><br />
"Analytické metódy a zdravie loveka", ISBN 978-80-969435-7-9<br />
- 115 -<br />
hotel Falkensteiner, Bratislava<br />
11. - 14. 10. 2010